Evotec inks drug discovery partnership with Lilly in metabolic diseases

Evotec inks drug discovery partnership with Lilly in metabolic diseases

Published: 37 minutes ago By Pankaj Singh

Evotec SE has reportedly entered into a drug discovery partnership with Eli Lilly and Company in the metabolic diseases field emphasizing diabetes and kidney diseases. The partnership uses the extensive track record and experience of Evote....

Stallergenes Greer enters research collaboration with Imperial College

Stallergenes Greer Ltd. has reportedly announced that it has entered into a research partnership with London’s Imperial College, on the discovery of biomarkers of allergen immunotherapy (AIT). This long-term research partnership, whi....

Pathr.ai partners with MG2 Corporation & The Lionesque Group

Pathr.ai has reportedly collaborated with The Lionesque Group and its parent company MG2 Corporation to introduce real-time analytics to pop-up shops at National Retail Federation’s show. Using the advanced spatial intelligence techn....

Worldwise acquires FurHaven to expand pet accessories business

A&M Capital Partners (AMCP), a financial institution, and an affiliated fund, A&M Capital Opportunities Fund, have recently announced the takeover of FurHaven Pet Products, Inc. by Worldwise. For those unversed, AMCP acquired Worldw....

Fosun Pharma & Insilico Medicine enter into collaboration agreement

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. and Insilico Medicine have reportedly entered a collaboration agreement to further the development and discovery of drugs using AI technology. This partnership comprises a drug discovery R&....

Arive secures Series A funding of USD 20 Mn led by Balderton Capital

Delivery firm Arive has reportedly raised a Series A funding of USD 20 million initiated by Balderton Capital with participation from Global Founders Capital, 468 Capital, La Famiglia, and Burda Principal Investments. Although the startup ....

Exagen & QMUL sign exclusive license agreement & partnership

Exagen Inc. and the Queen Mary University of London (QMUL) have reportedly signed an exclusive license agreement and a research collaboration. The partnership will emphasize the development and maximization of patent-pending approaches of ....

Industry Updates